High Efficacy of Sofosbuvir/Velpatasvir plus GS-9857 for 12 Weeks in Treatment-experienced Genotype 1-6 HCV-Infected Patients, Including those Previously Treated with Direct-acting Antivirals
a podcast by Raymond T. Chung, MD and Eric Lawitz, MD 
You are using an outdated browser. Please upgrade your browser or activate Google Chrome Frame to improve your experience.